Anne Arundel Medical Center and many area physicians have been fielding an inordinate number of phone calls related to the drug product preservative-free methylprednisolone acetate (80mg/ml)used for steroid injections and a correlation to a non-contagious, fungal form of meningitis.
On October 22, 2012, the FDA provided a list of a list of customers who received any product from the New England Compounding Center in Framingham, MA on or after May 21, 2012. The Maryland Department of Mental Health & Hygiene also issued a list Maryland facilities that have received implicated lots of methylprednisolone acetate from NECC, shown below:
Berlin Interventional Pain Management, Berlin, MD; Box Hill Surgery Center, Abingdon, MD; Greenspring Surgery Center, Baltimore, MD; Harford County Ambulatory Surgery Center, Edgewood, MD; Maryland Pain Specialists, Towson, MD; SurgCenter of Bel Air, Bel Air, MD; Zion Ambulatory Center, Baltimore, MD
Implicated lots of methylprednisolone:Lot # 05212012; Lot # 06292012; Lot # 08102012
Anne Arundel Medical Center’s pharmacy does not stock methylprednisolone acetate from NECC. The only drug in stock from this manufacturer is a rarely used alum bladder irrigation that is sequestered until more is known about the contamination at the company. The pharmacy team is working to stock up on the brand drug and alternatives for the potential ensuing shortage.
As of October 24, 2012, the FDA reported a total of 312 cases, including 24 deaths, in 17 states associated with NECC injectable steroids have been identified. to the fungal meningitis. All of those infected had received steroid injections to the spine, according to FDA officials. Methylprednisolone acetate is an injectable steroid product used to treat pain and inflammation. The FDA identified the manufacturer as New England Compounding Center (NECC), which conducted a recall of the drug. The FDA is working with state health departments to investigate the scope and cause of the outbreak. Read more here.